← Back to Clinical Trials
Recruiting NCT06836479

NCT06836479 Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06836479
Status Recruiting
Phase
Sponsor Stanford University
Condition Type 2 Diabetes Mellitus (T2DM)
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-01-08
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
NOURISH DietSelf-Selected Diet (Control)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-01-08 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators are hoping to determine whether tailoring the diet of someone with type 2 diabetes to their ethnic group while following American Diabetes Association guidelines can make a significant difference in their blood sugar controls. Participants will be required to wear a Continuous Glucose Monitor (CGM) for 1-month so that the investigators can compare blood sugar levels when participants are eating their routine diet vs. the culturally tailored diabetes diet.

Eligibility Criteria

Inclusion Criteria: * Self-identification as Asian Indian or Filipino * Diagnosed with T2DM * Can pick up meals from a designated area on the Stanford Campus * Willing to wear a CGM for 30 days Exclusion Criteria: * Currently taking insulin, GLP -1 and SGLT 2 * Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat * Those who, in the opinion of the investigators, cannot reliably complete the study protocol.

Contact & Investigator

Central Contact

Stephanie Ibe

✉ stephibe@stanford.edu

📞 732-610-1929

Principal Investigator

Minal Moharir, MD

PRINCIPAL INVESTIGATOR

Stanford University

Frequently Asked Questions

Who can join the NCT06836479 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes Mellitus (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06836479 currently recruiting?

Yes, NCT06836479 is actively recruiting participants. Contact the research team at stephibe@stanford.edu for enrollment information.

Where is the NCT06836479 trial being conducted?

This trial is being conducted at Stanford, United States.

Who is sponsoring the NCT06836479 clinical trial?

NCT06836479 is sponsored by Stanford University. The principal investigator is Minal Moharir, MD at Stanford University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology